RxSight RXST
NASDAQ RXST
$5.32 -0.06 (-1.12%)
At close: Nov 13, 2026 · 4:00 PM EST

RxSight (RXST) Sale and Maturity of Investments (2020 - 2026)

Updated

RxSight's Sale and Maturity of Investments - Total came in at $122 million for Q3 2026, up 103.3% from $60 million a year earlier and up 22.0% from the prior quarter.

Analysis

RxSight (RXST) Sale and Maturity of Investments (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, RxSight reported Sale and Maturity of Investments - Total of $422 million, up 87.6% year-over-year; for FY2025, it came in at $260 million, up 7.0% from FY2024.

  • Sale and Maturity of Investments - Total carries a five-year compound annual growth rate of 17.5% (FY2020 to FY2025).
  • Going back by year, Sale and Maturity of Investments - Total was $243 million in FY2024 (-4.7%), $255 million in FY2023 (unchanged), $255 million in FY2022 (+218.8%) and $80 million in FY2021 (-31.0%).
  • The Q3 2026 figure represents the highest quarterly Sale and Maturity of Investments - Total in data going back to Q3 2020.
  • Year-over-year, Sale and Maturity of Investments - Total has increased for four consecutive quarters, with growth averaging 42.4% over the last eight quarters.
  • The fastest year-over-year change in Sale and Maturity of Investments - Total over five years came in Q3 2022 (growth of 400.0%), and the weakest in Q1 2023 (a decline of 33.3%).
  • Business Quant data shows RXST's Sale and Maturity of Investments - Total at $100 million (Q2 2026), $110 million (Q1 2026) and $90 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn -
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn -
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn -
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 2.11 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 2.21 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 89.00 Mn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 27.00 Mn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 492.50 Mn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn -
10 RxSight 223.05 Mn -31.65 Mn 18.10 Mn 122.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 122.00 Mn
Jun 30, 2026 100.00 Mn
Mar 31, 2026 110.00 Mn
Dec 31, 2025 90.00 Mn
Sep 30, 2025 60.00 Mn
Jun 30, 2025 50.00 Mn
Mar 31, 2025 60.00 Mn
Dec 31, 2024 55.00 Mn
Sep 30, 2024 69.00 Mn
Jun 30, 2024 45.00 Mn
Mar 31, 2024 74.00 Mn
Dec 31, 2023 50.00 Mn
Sep 30, 2023 90.00 Mn
Jun 30, 2023 55.00 Mn
Mar 31, 2023 60.00 Mn
Dec 31, 2022 45.00 Mn
Sep 30, 2022 75.00 Mn
Jun 30, 2022 45.00 Mn
Mar 31, 2022 90.00 Mn
Dec 31, 2021 25.00 Mn
API Access

RxSight Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=RXST&period=max&api_key=YOUR_API_KEY